⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RNAZ News
TransCode Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
RNAZ
TransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026
prnewswire.com
RNAZ
TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
prnewswire.com
RNAZ
Form 8-K
sec.gov
RNAZ
Form 8-K
sec.gov
RNAZ
TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up
prnewswire.com
RNAZ
TransCode Therapeutics Announces Patent Advancements in Australia and Japan Strengthening Global IP Position in RNA-Based Immuno-Oncology
prnewswire.com
RNAZ
Join Today's Live Investor Webinar with TransCode Therapeutics
accessnewswire.com
RNAZ
Form 8-K
sec.gov
RNAZ
TransCode Therapeutics Announces Leadership Transition
prnewswire.com
RNAZ